OTCMKTS:BNOEF Bionomics (BNOEF) Stock Price, News & Analysis → Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad) Free BNOEF Stock Alerts $0.0034 0.00 (-43.33%) (As of 09/19/2023) Add Compare Share Share Today's Range$0.0034▼$0.003450-Day Range N/A52-Week Range$0.00▼$0.06Volume22,900 shsAverage Volume140,299 shsMarket Capitalization$4.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Bionomics alerts: Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About Bionomics Stock (OTCMKTS:BNOEF)Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.Read More BNOEF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BNOEF Stock News HeadlinesMay 9, 2024 | bbc.comKendrick Lamar’s beef with Drake and J Cole explainedApril 17, 2024 | bbc.co.ukChilli beef udon noodlesMarch 21, 2024 | msn.comBionomics to advance non-SSRI PTSD candidate to Phase IIIJanuary 5, 2024 | tmcnet.comBionomics to Present at Biotech Showcase™ 2024December 30, 2023 | bbc.co.ukPeter Bone MP loses seat as recall petition triggers by-electionDecember 6, 2023 | msn.comBionomics presents data on reliability of the Subjective Units of Distress ScaleOctober 16, 2023 | markets.businessinsider.comBionomics Secures Buy Rating Amidst Promising BNC210 Developments and Potential Market Entry AdvantageSeptember 29, 2023 | msn.comBionomics stock rockets 415% on positive study for PSTD drugSeptember 28, 2023 | proactiveinvestors.comBionomics shares soar almost 400% after positive phase IIb results from PTSD treatmentSeptember 28, 2023 | marketwatch.comBionomics Shares Take Flight on Positive PTSD Study ResultsSeptember 28, 2023 | marketwatch.comBionomics Shares Rally Premarket on Phase 2B PTSD Study SuccessSeptember 28, 2023 | markets.businessinsider.comBionomics: Phase 2b ATTUNE Trial With BNC210 Meets Primary Endpoint - Quick FactsSeptember 28, 2023 | msn.comBionomics announces positive results in trial of treatment for PTSDSeptember 26, 2023 | ftw.usatoday.comJay Norvell's beef with Deion Sanders and Colorado is so good for college footballSeptember 14, 2023 | finance.yahoo.comBionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSDJuly 9, 2023 | usatoday.comMike Trout suffers broken hamate bone, likely out six to eight weeksApril 27, 2023 | finance.yahoo.comBionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)March 10, 2023 | markets.businessinsider.comPositive Report for Bionomics (BNOX) from Evercore ISIMarch 8, 2023 | finance.yahoo.comBionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)March 3, 2023 | msn.comBears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' NowFebruary 10, 2023 | finance.yahoo.comBionomics Limited (BNOEF) Stock Historical Prices & Data - Yahoo FinanceDecember 15, 2022 | marketwatch.comBionomics Names Spyridon Papapetropoulos as President, CEODecember 15, 2022 | finance.yahoo.comBionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive OfficerNovember 21, 2022 | nz.finance.yahoo.comBionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United StatesNovember 17, 2022 | marketwatch.comBionomics Shares Drop 18% After ADS Offering PricesSee More Headlines Receive BNOEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/15/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Noncommercial research organizations Sub-IndustryN/A Current SymbolOTCMKTS:BNOEF CUSIPN/A CIK1191070 Webwww.bionomics.com.au Phone(188) 150-7400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,309,557,000Free FloatN/AMarket Cap$4.45 million OptionableNot Optionable Beta1.86 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Adrian Hinton BEC (Age 70)F.C.A., Financial Controller Comp: $205.67kDr. Spyridon Papapetropoulos M.D. (Age 50)Ph.D., CEO, Pres & Director Mr. Timothy M. Cunningham CPA (Age 60)CPA, M.B.A., Chief Financial Officer Prof. Paul Rolan D.C.P.S.A.F.F.P.M., F.R.A.C.P., M.B.B.S., M.D., Consultant Chief Medical Officer of Clinical NeuroscienceDr. Julie Kerner Ph.D.Sr. VP of Bus. OperationsDr. Atul R. Mahableshwarkar DFAPAM.D., Acting Chief Medical OfficerMs. Suzanne Irwin B.Com.FCIS, Company Sec.More ExecutivesKey CompetitorsAgape ATPNASDAQ:ATPCQT ImagingNASDAQ:QTIKindly MDNASDAQ:KDLYVBI VaccinesNASDAQ:VBIVNutralife BiosciencesOTCMKTS:NTFUView All Competitors BNOEF Stock Analysis - Frequently Asked Questions How have BNOEF shares performed in 2024? Bionomics' stock was trading at $0.0034 on January 1st, 2024. Since then, BNOEF stock has increased by 0.0% and is now trading at $0.0034. View the best growth stocks for 2024 here. How do I buy shares of Bionomics? Shares of BNOEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BNOEF) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.